Catch up on this quarter's essential physical and massage therapy research. Journal Watch brings you all the most important journal discoveries with our own unique Co-Kinetic take-home messages. This is one of our most popular sections of content aimed at saving you time and money not having to trawl the research journals!
Register (or sign in) below to read three of the best research stories in this quarter's roundup without needing a subscription.
Register today to access free content
Buy today for £7.49
This article is also available within other
subscriptions. View options
Bob Bramah BSc, MSMA, MSMM, MCSP is a chartered physiotherapist specialising in sports soft tissue therapy. He has worked in Premiership Rugby and Football and with the GB National teams for Basketball, Volleyball and Wheelchair Rugby and the England cricket team.
In addition to a private practice in Wigan, Bob is a lecturer in manual therapy at the University of Salford and is the editor of the Journal Watch section of sportEX.
He was a founder member of the Sports Massage Association and is Vice-chair of the Chartered Society of Physiotherapy professional network for massage and Soft Tissue Therapy.
Thank you. Your account has been created and you have now been logged in. We will send you an email so that you can set your password for future use.
Unfortunately your current subscription does not include access to the new Co-Kinetic Business Growth and Marketing section. This is either because you have an old legacy Full Site subscription which requires an upgrade or you have another subscription which doesn't include access to the Business Growth element of the site.
This new part of the Co-Kinetic platform is designed to:
To access this new section, we need you to upgrade to add the Business Growth subscription to your account. (more details here).
Don't worry, it's RISK FREE. If you don't wish your subscription to continue after this time, simply
cancel your Business Growth subscription before the trial expires and your original content
subscription will continue as before.